1. Home
  2. WAT vs EQH Comparison

WAT vs EQH Comparison

Compare WAT & EQH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAT
  • EQH
  • Stock Information
  • Founded
  • WAT 1958
  • EQH 1859
  • Country
  • WAT United States
  • EQH United States
  • Employees
  • WAT N/A
  • EQH N/A
  • Industry
  • WAT Biotechnology: Laboratory Analytical Instruments
  • EQH Specialty Insurers
  • Sector
  • WAT Industrials
  • EQH Finance
  • Exchange
  • WAT Nasdaq
  • EQH Nasdaq
  • Market Cap
  • WAT 17.4B
  • EQH 16.2B
  • IPO Year
  • WAT 1995
  • EQH N/A
  • Fundamental
  • Price
  • WAT $378.89
  • EQH $43.38
  • Analyst Decision
  • WAT Buy
  • EQH Buy
  • Analyst Count
  • WAT 13
  • EQH 11
  • Target Price
  • WAT $379.00
  • EQH $64.18
  • AVG Volume (30 Days)
  • WAT 626.0K
  • EQH 2.8M
  • Earning Date
  • WAT 11-04-2025
  • EQH 11-04-2025
  • Dividend Yield
  • WAT N/A
  • EQH 2.51%
  • EPS Growth
  • WAT 3.82
  • EQH N/A
  • EPS
  • WAT 10.88
  • EQH N/A
  • Revenue
  • WAT $3,105,638,000.00
  • EQH $12,224,000,000.00
  • Revenue This Year
  • WAT $7.12
  • EQH $17.79
  • Revenue Next Year
  • WAT $6.22
  • EQH $3.00
  • P/E Ratio
  • WAT $34.63
  • EQH N/A
  • Revenue Growth
  • WAT 6.90
  • EQH 13.38
  • 52 Week Low
  • WAT $275.05
  • EQH $41.39
  • 52 Week High
  • WAT $423.56
  • EQH $56.61
  • Technical
  • Relative Strength Index (RSI)
  • WAT 66.62
  • EQH 30.77
  • Support Level
  • WAT $374.41
  • EQH $44.35
  • Resistance Level
  • WAT $391.79
  • EQH $45.96
  • Average True Range (ATR)
  • WAT 11.16
  • EQH 1.33
  • MACD
  • WAT -0.03
  • EQH -0.24
  • Stochastic Oscillator
  • WAT 75.37
  • EQH 13.76

About WAT Waters Corporation

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

About EQH Equitable Holdings Inc.

Equitable Holdings Inc is a financial services company in the U.S. The company provides variable annuities, tax-deferred investment and retirement plans, employee benefits, and protection solutions for individuals, families, and small businesses. Its business segments include Individual Retirement, Group Retirement, Asset Management, Protection Solutions, Wealth Management, and Legacy. It generates the majority of its revenue from the Asset Management segment which provides diversified investment management and related solutions globally to a broad range of clients through three main client channels - Institutional, Retail, and Private Wealth.

Share on Social Networks: